Ndt Pharmaceuticals Stock Performance
| NDTP Stock | USD 1.50 0.30 16.67% |
NDT Pharmaceuticals holds a performance score of 6 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of -3.14, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning NDT Pharmaceuticals are expected to decrease by larger amounts. On the other hand, during market turmoil, NDT Pharmaceuticals is expected to outperform it. Use NDT Pharmaceuticals potential upside, as well as the relationship between the kurtosis and day typical price , to analyze future returns on NDT Pharmaceuticals.
Risk-Adjusted Performance
Mild
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in NDT Pharmaceuticals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Even with relatively fragile basic indicators, NDT Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point. ...more
NDT |
NDT Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 140.00 in NDT Pharmaceuticals on September 28, 2025 and sell it today you would earn a total of 10.00 from holding NDT Pharmaceuticals or generate 7.14% return on investment over 90 days. NDT Pharmaceuticals is currently generating 1.6238% in daily expected returns and assumes 19.0511% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than NDT, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
NDT Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for NDT Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as NDT Pharmaceuticals, and traders can use it to determine the average amount a NDT Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0852
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | NDTP | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average NDT Pharmaceuticals is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NDT Pharmaceuticals by adding it to a well-diversified portfolio.
NDT Pharmaceuticals Fundamentals Growth
NDT Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of NDT Pharmaceuticals, and NDT Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on NDT Pink Sheet performance.
| Current Valuation | 123.75 K | |||
| Shares Outstanding | 1.12 M | |||
| Price To Book | 49.36 X | |||
| Earnings Per Share | (1.86) X | |||
About NDT Pharmaceuticals Performance
Assessing NDT Pharmaceuticals' fundamental ratios provides investors with valuable insights into NDT Pharmaceuticals' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the NDT Pharmaceuticals is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
NDT Pharmaceuticals Inc., a biotechnology company, focuses on developing various therapies for severe neurological disorders associated with traumatic brain Injury. Ndt Pharmaceuticals is traded on OTC Exchange in the United States.Things to note about NDT Pharmaceuticals performance evaluation
Checking the ongoing alerts about NDT Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for NDT Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| NDT Pharmaceuticals is way too risky over 90 days horizon | |
| NDT Pharmaceuticals may become a speculative penny stock | |
| NDT Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| NDT Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years |
- Analyzing NDT Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether NDT Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining NDT Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating NDT Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of NDT Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of NDT Pharmaceuticals' pink sheet. These opinions can provide insight into NDT Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for NDT Pink Sheet Analysis
When running NDT Pharmaceuticals' price analysis, check to measure NDT Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NDT Pharmaceuticals is operating at the current time. Most of NDT Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NDT Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NDT Pharmaceuticals' price. Additionally, you may evaluate how the addition of NDT Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.